Form 4: Cardinal Health CEO Jason Hollar Reports Stock Transactions
SEC Form 4 Filing
Cardinal Health's CEO, Jason Hollar, reports the acquisition and disposal of company shares, including transactions related to vesting of restricted stock units and performance share units.
Summary
- Jason Hollar, CEO of Cardinal Health, filed a Form 4 detailing changes in beneficial ownership.
- On August 15, 2024, shares were withheld to cover tax obligations related to the vesting of restricted share units (RSUs) and performance share units.
- Specifically, 30,275 shares were withheld at a price of $106.36.
- Also on August 15, 2024, Hollar was granted 48,188 restricted share units with no price specified.
- On August 16, 2024, 7,875 shares were withheld at $107.91 to cover taxes related to vesting RSUs.
- Hollar sold 26,716 shares on August 16, 2024, at a weighted average price of $108.87.
- He further sold 46,455 shares on August 19, 2024, at a weighted average price of $109.02.
- Following these transactions, Hollar directly owns 197,636 common shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Future Outlook
The restricted share units granted on August 15, 2024, vest in three equal annual installments beginning on August 15, 2025.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Comparing Jason Hollar's transactions to those of CEOs at similar companies like McKesson or AmerisourceBergen would provide context.
- For example, if other CEOs in the healthcare distribution industry are also selling shares, it could indicate broader industry trends or concerns.
- Conversely, if Hollar's transactions are significantly different, it could be specific to Cardinal Health's situation.
Stakeholder Impact
- Shareholders may be interested in the CEO's stock transactions as an indicator of management's confidence in the company.
- The transactions themselves are unlikely to have a significant impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Withholding of shares for tax obligations related to vesting of RSUs and PSUs; Grant of restricted share units. |
| 08/16/2024 | Withholding of shares for tax obligations related to vesting of RSUs; Sale of shares. |
| 08/19/2024 | Sale of shares. |
| 08/15/2025 | First vesting date for restricted share units granted on August 15, 2024. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.